Brief: Charles River, Labcorp, And FDA Collaborate To Validate New Preclinical Methods For Abuse Potential Assessment
Yesterday 23:19
BRIEF-Charles River, Labcorp, And FDA Collaborate To Validate New Preclinical Methods For Abuse Potential Assessment Oct 22 (Reuters) - Charles River Laboratories International, Inc. CRL.N:
CHARLES RIVER, LABCORP, AND FDA COLLABORATE TO VALIDATE NEW PRECLINICAL METHODS FOR ABUSE POTENTIAL ASSESSMENT
CHARLES RIVER LABORATORIES INTERNATIONAL - AGREEMENT ESTABLISHES JOINT FRAMEWORK FOR STANDARDIZED ABUSE POTENTIAL METRICS IN PRECLINICAL MODELS
Source text: ID:nBw7wyCW6a
Further company coverage: CRL.N
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Charles River Laboratories International
See all newsBrief: Charles River, Labcorp, And FDA Collaborate To Validate New Preclinical Methods For Abuse Potential Assessment
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
European life sciences stocks rise on strong sector momentum